BABA vs GRBK

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

GRBK presents a conflicting profile characterized by a weak Piotroski F-Score of 3/9 and a lack of Altman Z-Score data, indicating deteriorating fundamental health. While the company maintains an exceptionally strong balance sheet with low debt (D/E 0.17) and high liquidity, it is currently facing a significant growth contraction with YoY earnings down 23%. The stock trades below its Graham Number ($81.66) but significantly above its growth-based intrinsic value ($49.49) and analyst target ($62.00). Overall, the strong historical performance and low valuation multiples are currently offset by negative growth trends and bearish insider sentiment.